Home | Business News | Browse by Publication | P | Pharma Marketletter

GPC Biotech extends license for MorphoSys' antibodies.

Publication: Pharma Marketletter
Publication Date: 02-FEB-04
Format: Online
Delivery: Immediate Online Access
Full Article Title: GPC Biotech extends license for MorphoSys' antibodies.(Brief Article)

Article Excerpt
GPC Biotech has extended its exclusive license for fellow German company...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Crucell nointed Ronald Brus as CEO.(Dinko Valerio has stepped down )(B..., February 02, 2004
France's LEEM names Bayer chief Jean-Philippe Milon to board.(Les Entr..., February 02, 2004
Shire Pharma names Anita Graham exec VP, human resources.(Brief Articl..., February 02, 2004
AstraZeneca launches new aerosols production line.(Brief Article), February 02, 2004
SPECTRUM.(Brief Article)(Illustration), February 02, 2004

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.